Format
Sort by

Send to

Choose Destination

Search results

Items: 6

1.

Hand-held high-resolution spectral domain optical coherence tomography in retinoblastoma: clinical and morphologic considerations.

Rootman DB, Gonzalez E, Mallipatna A, Vandenhoven C, Hampton L, Dimaras H, Chan HS, Gallie BL, Heon E.

Br J Ophthalmol. 2013 Jan;97(1):59-65. doi: 10.1136/bjophthalmol-2012-302133.

PMID:
23104902
2.

Vorapaxar in the secondary prevention of atherothrombotic events.

Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy SA; TRA 2P–TIMI 50 Steering Committee and Investigators..

N Engl J Med. 2012 Apr 12;366(15):1404-13. doi: 10.1056/NEJMoa1200933.

3.

The characterization of retinal phenotype in a family with C1QTNF5-related late-onset retinal degeneration.

Vincent A, Munier FL, Vandenhoven CC, Wright T, Westall CA, Héon E.

Retina. 2012 Sep;32(8):1643-51. doi: 10.1097/IAE.0b013e318240a574.

PMID:
22277927
4.

Anterior segment imaging in pediatric ophthalmology.

Mireskandari K, Tehrani NN, Vandenhoven C, Ali A.

J Cataract Refract Surg. 2011 Dec;37(12):2201-10. doi: 10.1016/j.jcrs.2011.09.026. Review.

PMID:
22108115
5.

BEST1-related autosomal dominant vitreoretinochoroidopathy: a degenerative disease with a range of developmental ocular anomalies.

Vincent A, McAlister C, Vandenhoven C, Héon E.

Eye (Lond). 2011 Jan;25(1):113-8. doi: 10.1038/eye.2010.165.

6.

Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma.

Mulvihill A, Budning A, Jay V, Vandenhoven C, Heon E, Gallie BL, Chan HS.

Arch Ophthalmol. 2003 Aug;121(8):1120-4.

PMID:
12912689
Items per page

Supplemental Content

Loading ...
Support Center